Security key
89455T109
TREACE MEDICAL CONCEPTS, INC. - Common Stock (TMCI)
CUSIP: 89455T109
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 246,715
- Total 13F value
- $990,952
- Share change
- -9,436
- SEC-reported price per share
- $3.98
- Number of holders
- 21
- Value change
- +$99,008
- Number of buys
- 14
- Number of sells
- 9
- Shares outstanding
- 63,954,667
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
21
Top holders
10
TMCI full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q3 2025
TREACE MEDICAL CONCEPTS, INC. SEC filings
TREACE MEDICAL CONCEPTS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89455T109
Recent filing periods:
Ownership snapshot
Top reported holders of TMCI - TREACE MEDICAL CONCEPTS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
Treace John T.
Comparable rows
15/15
Latest evidence
10 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.8%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 9.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
9.8%
GAGNON SECURITIES LLC
9.6%
BANK OF AMERICA CORP /DE/
5.5%
MORGAN STANLEY
3.4%
WILLIAM BLAIR INVESTMENT MANAGEME...
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
9.8%
|
$12,791,640
6,364,000 shares
|
$0 | 31 Mar 2026 |
| GAGNON SECURITIES LLC |
13D/G
13F
Neil Gagnon · Company
|
9.6%
|
$15,355,268
6,142,107 shares
|
+$5,406,632 | 31 Dec 2025 |
| BANK OF AMERICA CORP /DE/ |
13D/G
13F
Company
|
5.5%
|
$7,102,886
3,533,774 shares
|
$0 | 31 Mar 2026 |
| MORGAN STANLEY |
13D/G
13F
Company
|
3.4%
|
$13,931,448
2,091,809 shares
|
$0 | 31 Dec 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13D/G
|
1.8%
|
$2,863,745
1,145,498 shares
|
-$6,297,435 | 31 Dec 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
1.5%
from 13D/G
|
$4,884,834
3,896,912 shares
mixed-class rows
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
246,715
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q3 2025 Across Filers
Q3 2025 holders
117
Q2 2026 holders
21
Holder diff
-96
| Investor | Q3 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend